Aims:To evaluate the proliferative activity of urothelial neoplasms, compare it with that of the normal urinary tract epithelium, and determine its relation to morphological grade and presence of invasion. Methods: Multiple biopsy specimens from 53 individuals-eight normal controls, five patients with severe urothelial atypia, and 40 with transitional cell carcinomas (TCCs)-were studied using in vitro bromodeoxyuridine (BrdU) incorporation, Ki67 antigen expression, and quantitation of the nucleolar organiser regions (NORs). Results: The percentage of nuclei labelled by BrdU (BrdU index) correlated well with the percentage of nuclei expressing the Ki67 antigen (Ki67 index). These proliferation indices were very low (less than 0-1% in 60% of samples) in the urothelium of normal controls and the morphologically unremarkable epithelium of patients with TCCs. Non-invasive TCCs had increased proliferation (BrdU index 6-32 (SD 0-8)%, Ki67 index 5 04 (0.6)% but lagged behind the invasive tumours (BrdU 20-9 (3-2)%, Ki67 18*6 (2-8)%). The average NOR count was 1-57 (0-03) Because each of these indices of cell growth is associated with a different aspect of the cell cycle, the results obtained by the different approaches may be complementary rather than interchangeable. This is particularly true for neoplastic cells which often have multiple and diverse abnormalities of growth.
lagged behind the invasive tumours (BrdU 20-9 (3-2)%, Ki67 18*6 (2-8)%). The average NOR count was 1-57 (0-03) in morphological normal epithelium, which increased progressively with grade in non-invasive TCCs, but varied greatly in invasive tumours and did not correlate with the proliferation indices. The spectrum of values for both proliferation indices and NORs was particularly wide in grade 2 TCCs. Severe atypias without exophytic growth had an increase in BrdU and Ki67 indices comparable with that found in grade 3-4 invasive TCCs; these also had the highest NORs per nucleus. Conclusions: The growth potential of urothelial neoplasms is an important indicator of their aggressive course. In particular, growth indices over 10% are strongly associated with the presence of invasion. Papillary grade 2 The growth rate of tumours is an important determinant of their potential for progression and dissemination. Furthermore, knowledge of the specific growth characteristics of a neoplasm is a prerequisite for the development of effective therapeutic agents. In the case of urothelial neoplasia, information about the proliferative capacity of tumours at preinvasive stages may be important in predicting recurrences or progression in grade and stage.
Until recently, the study of Because each of these indices of cell growth is associated with a different aspect of the cell cycle, the results obtained by the different approaches may be complementary rather than interchangeable. This is particularly true for neoplastic cells which often have multiple and diverse abnormalities of growth.
For these reasons, we investigated the proliferative patterns of the normal and neoplastic luman urothelium using all three approaches in parallel. We then attempted to explore the interrelationships and relevance of the results to the degree of cytological and biological malignancy.
Methods
Tissues consisted of biopsy and resection specimens from 53 patients of the Minneapolis VA Medical Center, all men with a mean age of 62 years. Samples of normal urothelium from eight patients without a history of urothelial neoplasia were used as controls. Morphologically normal urothelium was also obtained from 17 of the patients who also had transitional cell carcinomas (TCCs). Five patients had severe epithelial atypia without an exophytic or invasive component. Among the 40 urothelial neoplasms, there were 29 papillary non-invasiveTCCs, 10 invasive cancers, stages TI-T3, and one inverted papilloma.
After removal, the tissue was placed in RPMI (Gibco, Bethesda Research Laboratories, Grand Island, New York) and transferred immediately to the laboratory where it was divided for the following procedures:
(1) incubation with BrdU followed by immunohistochemical detection of the labelled nuclei; (2) immunohistochemistry using the Ki67 monoclonal antibody on frozen tissues; (3) the AgNOR reaction on sections of paraffin wax embedded tissue; (4) conventional histopathological examination of sections stained with haematoxylin and eosin.
For in vitro BrdU incorporation, the tissue was diced into small fragments (greatest dimension 0-2-0 3 cm) using a tissue chopper, rinsed in RPMI medium placed in 2 All reactions were performed in duplicate and in parallel with their normal counterparts whenever these were available. Positive controls with an established level of reactivity were always included to assure quantitative reproducibility.
The counting of positive nuclei was performed with the help of an eyepiece graticule containing 1 cm2 grid divided into 100 equal squares. Duplicate sections from the same block were thoroughly screened and representative fields were selected to reflect the overall cellularity and numbers of positive nuclei. At least 2000 cells were counted per section; the ratio of positive over total number of nuclei was expressed as the per cent BrdU or Ki67 index.
A similar set up was used to count the NORs; the number of nuclei and the number of argyrophilic nuclear dots were simultaneously recorded and the average number of NORs per nucleus was calculated for each biopsy specimen. normal tissues and between 0 1 and 2% in 29% (fig 1) . Rarely were indices over 2% found in morphologically normal transitional epithelium (the highest Ki67 was 3-6% and highest BrdU 4-2%). It should be emphasised that cases with inflammation or metaplastic changes were excluded from the normal category.
The counting of BrdU labelled nuclei was facilitated by the high contrast between the BrdU positive and negative nuclei; the results were highly reproducible. The counts of Ki67 positive nuclei were less consistent probably because of the variable intensity of the nuclear reactions within the same section which introduced an element of subjectivity and might have resulted in underestimation of weak reactions. Furthermore, some variability was noted in the performance of two different batches of Ki67. This was corrected by adjust- carcinoma in situ and showed noticeably increased cell proliferation with BrdU indices between 12% and 25% and Ki67 indices between 7% and 32%. Positively staining nuclei were randomly distributed throughout the thickness of the epithelium (fig 5) . In all five cases the average AgNORs per nucleus exceeded the normal values and ranged between 2 and 3-6 with an average of 2-89 (0 3) (fig 4) .
TRANSITIONAL CELL NEOPLASMS
The BrdU index was greater than 2% in all urothelial neoplasms and the Ki67 index also exceeded 2% in all but one case. The only *+@ exception was an inverted transitional cell ' papilloma which had a Ki67 index of 0 7%. In about 80% of non-invasive TCCs the two proliferation indices fell between 2% and 10%. In 90% of the invasive carcinomas the BrdU index was over 10% and in 80% of them the Ki67 index also exceeded 10%. A good ,':.>s s correlation between the two indices was found in 25 cases of TCCs (15 non-invasive and 10 invasive) for which both indices were calculated ( fig 6) . We found that the normal urothelium has a very low proliferation rate which in most cases is less than 0-1% by either the BrdU incorporation or the Ki67 expression. Similar low values were found when incorporated 3H-thymidine was used to identify cells in S phase.'8 Both methods indicated the existence of growth centres and showed that the proliferating capacity is predominantly, but not exclusively, localised in the basal layers. The AgNORs were consistent in the normal urothelium and fell, in 70% of cases, between 1 2 and 1 7 per nucleus. Because the results for the morphologically normal urothelium from patients with TCCs were similar to those for controls, no evidence for generalised cellular unrest was found in the bladder mucosas that harbour neoplasms. It is of course possible that the urothelium of patients with bladder cancer is capable of exaggerated response to growth stimuli despite its normal baseline proliferation rate. So far, our studies on the expression of the growth related receptors for transferrin and epidermal growth factor have shown that normal mucosas from patients with TCCs do not deviate from those of the controls.19 If a hyperresponsiveness exists it does not result from overexpression of these growth related receptors. Specimens with inflammatory and neoplastic changes were excluded from the normal category and only biopsies containing well preserved, full thickness epithelium were considered suitable for quantitative evaluation. These selection criteria limited the variability of the normal values and reduced the possibility of deviations secondary to reactive conditions.
A noticeable increase in the proliferation indices as well as in the number of AgNORs was found in all specimens with severe atypia-CIS (also called intraepithelial neoplasia) despite the absence of an exophytic or infiltrative growth. This indicates that, in these conditions, there is a pronounced acceleration of the turnover rate of the epithelium. The rapidly proliferating epithelium does not pile up or break through the basal lamina but exfoliates on a much greater scale than normally and thus a large number of cells are found in the urine. The large number of exfoliated cells renders the cytological examination of the urine an excellent diagnostic tool in cases of growth capacity into consideration when grading their invasive potential.
The heterogeneity of grade 2 TCCs was also apparent in the scatter of the average number of AgNORs per nucleus, from 1 2 to 3, which spans the spectrum between the lowest normal value to the highest among grade 3 tumours. Interestingly, the grade 2 TCCs show similar heterogeneity for the expression of other markers of aggressive behaviour, such as "loss" of the normally expected blood group antigen(s). 22 The presence of growth centres in many of the papillary tumours shows that cell growth in neoplasia is not uniform; sometimes it follows a distribution resembling the normal state with the proliferating cells distributed predominantly along the basal lamina of the papillary formations or invasive tumour islands, while, at other times, it appears chaotic with irregularly distributed foci of growth. Evidence that this is a genuine phenomenon and not a methodological artefact is provided by the similarity of the growth patterns for both BrdU and Ki67 reactions and by the concurrence in the same fields of clustered positive nuclei and mitoses. The fact that BrdU or Ki67 positive nuclei far outnumber the mitotic count confirms the much shorter duration of the actual mitosis compared with that of the S phase. Theoretically, Ki67 is expected to exceed the BrdU index because it identifies nuclei in several phases of the cycle and is not restricted to the S phase. This association was not demonstrated in our material possibly because we adjusted the antibody dilution to achieve a sharp cutoff point of the positive reactions and thus we might have identified mostly nuclei in late S-G2 phase which express strongly the Ki67 antigen. On In general, the mitotic count underestimates the growth potential of the papillary TCCs which far exceeds the normal state even in low grade tumours. Furthermore, the growth acceleration in preinvasive neoplasia appears to antedate the cytological changes on which the current grading system is based. We plan to follow the evolution of these tumours to clarify the time sequence of the three phenomena: proliferation, increased atypia, invasion.
Remarkably, the invasive carcinomas had much higher BrdU and Ki67 indices compared with non-invasive TCCs, a finding similar to that reported by Mellon et 
